rs11558471 — SLC30A8 SLC30A8 Zinc Transport Depth Variant

SLC30A8 3′-UTR — A Second Window on the Zinc-Insulin Axis

The SLC30A8 gene¹¹ SLC30A8 gene
SLC30A8 encodes the ZnT8 zinc transporter, expressed almost exclusively in pancreatic beta cells, where it pumps zinc into insulin secretory granules sits at one of the most replicated type 2 diabetes risk loci in the human genome. Most attention has focused on the missense variant rs13266634 (Arg325Trp)²² rs13266634 (Arg325Trp)
rs13266634 changes amino acid 325 from arginine to tryptophan and is the lead coding variant at this locus, but the locus harbors additional variants with independent functional significance. rs11558471 is a 3′ untranslated region (3′-UTR) variant that provides a distinct layer of information about how this locus influences ZnT8 biology and metabolic risk.

The Mechanism

rs11558471 sits in the 3′-UTR of SLC30A8 — the portion of the mRNA that is transcribed but not translated into protein. This region controls mRNA stability, translation efficiency, and the binding of regulatory microRNAs. Unlike rs13266634, which changes the ZnT8 protein sequence, rs11558471 influences how much ZnT8 protein the beta cell produces.

A 2023 study mapping the chromatin architecture of the SLC30A8 locus³³ 2023 study mapping the chromatin architecture of the SLC30A8 locus
Hu et al. Multiple genetic variants at the SLC30A8 locus affect local super-enhancer activity and influence pancreatic β-cell survival and function. FASEB Journal, 2023 identified an islet-selective super-enhancer cluster spanning ~293 kb near the SLC30A8 promoter. Within this landscape, rs11558471 showed the most significantly imbalanced allele-specific expression of any variant tested (⁴⁴ p=4.64×10⁻¹⁴): the risk A allele is preferentially transcribed over the protective G allele. This means A/A carriers produce more ZnT8 protein — and importantly, CRISPR deletion of the enhancer regions in human beta cells reduced SLC30A8 expression and improved glucose-stimulated insulin secretion, consistent with the counterintuitive finding that lower ZnT8 activity is metabolically beneficial.

rs11558471 is in very tight linkage disequilibrium⁵⁵ linkage disequilibrium
Linkage disequilibrium (LD) means two variants are inherited together so frequently they carry correlated information; r²=0.96 means 96% of the statistical variance of one variant is explained by the other with rs13266634 (r²=0.96), so most people who carry the rs11558471 A allele also carry the rs13266634 C (risk) allele. They tag the same biological signal through complementary mechanisms: one affecting protein structure, the other affecting expression level.

The Evidence

A 14-cohort meta-analysis⁶⁶ 14-cohort meta-analysis
Zheng J-S et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes, 2011 of up to 45,821 participants established rs11558471 A as the glucose-raising allele and showed a significant gene-nutrient interaction: each additional milligram per day of total zinc intake attenuated the glucose-raising effect of the A allele (β = −0.0017 per A allele per mg/day zinc, interaction p=0.005). The effect was dose-responsive — A/A homozygotes benefited roughly twice as much from increasing zinc intake as A/G heterozygotes, and the interaction was significant only for total zinc (including supplements), not dietary zinc alone.

In a Malay population study⁷⁷ Malay population study
Teh AL et al. Increased DNA methylation of the SLC30A8 gene promoter is associated with type 2 diabetes in a Malay population. Clinical Epigenetics, 2015 of 992 subjects, the A allele was significantly associated with type 2 diabetes (OR=1.334, 95% CI 1.110–1.602, p=0.002). The same study found that T2D patients also showed higher methylation of the SLC30A8 promoter compared to normoglycaemic controls (82.9% vs 80.1%, p=0.014), suggesting that both genetic variation and epigenetic silencing converge to reduce ZnT8 function in diabetes.

A Chinese Han population study⁸⁸ Chinese Han population study
Xu J et al. SLC30A8 (ZnT8) variations and type 2 diabetes in the Chinese Han population. Genetics and Molecular Research, 2012 confirmed the risk association: the AA genotype was found in 46% of T2D cases versus 24% of controls, and A-containing haplotypes predicted diabetes risk independently of rs13266634.

In South Asian Punjabi populations⁹⁹ South Asian Punjabi populations
Chambers JC et al. Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes. PLOS One, 2011, the A allele was nominally associated with higher fasting glucose (β=0.063, p=0.015) in normoglycaemic controls.

A small study of postmenopausal women¹⁰¹⁰ postmenopausal women
Costa SK et al. Relationship between the single nucleotide polymorphism rs11558471 in the SLC30A8/ZnT8 gene and cardiometabolic markers in postmenopausal women. Biological Trace Element Research, 2023 found that G allele carriers had significantly lower LDL-cholesterol than A/A homozygotes (p=0.035), adding a lipid dimension to the variant's metabolic footprint.

Practical Implications

The actionable insight from this variant is the same as from rs13266634 — zinc nutrition modifies risk — but with a mechanistic twist: here the issue is ZnT8 overexpression, not just altered protein function. The 14-cohort data show that zinc supplementation (not just dietary zinc alone) is the relevant lever for A allele carriers, and that A/A homozygotes gain the most from optimizing their zinc status.

For G allele carriers, this locus is a partial explanation for naturally efficient beta-cell zinc handling and lower T2D risk — their beta cells produce less ZnT8, which paradoxically supports better insulin secretion.

Interactions

rs11558471 and rs13266634 are in tight LD (r²=0.96) and largely tag the same signal. Carriers of the A allele here almost invariably carry the C allele at rs13266634. The combined picture is higher ZnT8 expression (rs11558471 mechanism) driving a protein with altered zinc transport kinetics (rs13266634 mechanism), converging on impaired first-phase insulin release.

The separate 3′-UTR variants rs3802177 and rs11558471 together represent expression- level regulation at the same locus; their joint contribution to allele-specific expression suggests this genomic region is under complex regulatory control that single-variant analyses can miss.